PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 1999Arteriosclerosis Thrombosis and Vascular Biology35 citationsOpen Access

Overexpression of Human Hepatic Lipase and ApoE in Transgenic Rabbits Attenuates Response to Dietary Cholesterol and Alters Lipoprotein Subclass Distributions

View Full Paper
CBCarlo M. BarbagalloJFJianglin FanPBPatricia J. Blanche

Key Result

Expression of human hepatic lipase or apoE in transgenic rabbits reduced the plasma cholesterol response to a high-cholesterol diet by 75% and 60%, respectively, compared with controls.

Structured PICO

Does overexpression of human hepatic lipase and apoE alter plasma cholesterol and lipoprotein subclass distributions in response to dietary cholesterol in transgenic rabbits?

P
Population
Transgenic rabbits expressing human hepatic lipase or apoE, compared to nontransgenic controls, fed a cholesterol-supplemented diet for 10 weeks.
I
Intervention
Expression of human hepatic lipase (HL), human apoE, or combined expression of apoE and HL, with a chow diet supplemented with 0.3% cholesterol and 3.0% soybean oil for 10 weeks
C
Comparator
Nontransgenic control rabbits on the same supplemented diet
O
Outcome
Plasma cholesterol and lipoprotein subclass distributions (VLDL, IDL, LDL, HDL)surrogate

Human hepatic lipase and apoE have complementary and synergistic functions in reducing plasma cholesterol and altering lipoprotein metabolism in response to dietary cholesterol.

Abstract

The effect of the expression of human hepatic lipase (HL) or human apoE on plasma lipoproteins in transgenic rabbits in response to dietary cholesterol was compared with the response of nontransgenic control rabbits. Supplementation of a chow diet with 0.3% cholesterol and 3.0% soybean oil for 10 weeks resulted in markedly increased levels of plasma cholesterol and VLDL and IDL in control rabbits as expected. Expression of either HL or apoE reduced plasma cholesterol response by 75% and 60%, respectively. The HL transgenic rabbits had substantial reductions in medium and small VLDL and IDL fractions but not in larger VLDL. LDL levels were also reduced, with a shift from larger, more buoyant to smaller, denser particles. In contrast, apoE transgenic rabbits had a marked reduction in the levels of large VLDLs, with a selective accumulation of IDLs and large buoyant LDLs. Combined expression of apoE and HL led to dramatic reductions of total cholesterol (85% versus controls) and of total VLDL+IDL+LDL (87% versus controls). HDL subclasses were remodeled by the expression of either transgene and accompanied by a decrease in HDL cholesterol compared with controls. HL expression reduced all subclasses except for HDL2b and HDL2a, and expression of apoE reduced large HDL1 and HDL2b. Extreme HDL reductions (92% versus controls) were observed in the combined HL+apoE transgenic rabbits. These results demonstrate that human HL and apoE have complementary and synergistic functions in plasma cholesterol and lipoprotein metabolism.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Barbagallo et al. (1999) studied Hypercholesterolemia. Expression of human hepatic lipase (HL) and/or human apoE vs. Nontransgenic control rabbits was evaluated on Plasma cholesterol response. Expression of human hepatic lipase or apoE in transgenic rabbits reduced the plasma cholesterol response to a high-cholesterol diet by 75% and 60%, respectively, compared with controls.

synapsesocial.com/papers/6a224c4821b01fc9abab5081https://doi.org/10.1161/01.atv.19.3.625
Ask AI
Helpful
Bookmark
Share
View Full Paper